Molecular biology enzymes, kits and reagents market worth USD 22 trillion by 2026 at a CAGR of 15.8%

Newly Compiled Report from Future Market Insights Offers Growth Prospects of Global Molecular Biology Enzymes, Kits and Reagents Market for the period between 2017 and 2026. The report predicts that the market will register splendid growth till 2026. by the end of 2026.

Technological advances leading to increased efficiency and greater accuracy of molecular biology enzymes, kits and reagents

Many technological advancements have been made by manufacturers of enzymes, kits and molecular biology reagents, which are focused on developing advanced products with the aim of improving their product portfolio. Advanced products facilitate research processes with offerings such as increased efficiency and greater accuracy. One of the greatest examples of this is the SMART Digest kit developed by Thermo Fisher Scientific, Inc., designed especially for biopharmaceutical and proteomics applications. This kit enables the generation of high-quality data, while reducing the time required for sample preparation. The adoption of molecular biology enzymes, kits and reagents will be further propelled by huge investments made in research and development by the pharmaceutical and biotechnology industries coupled with the provision of several reimbursements for molecular diagnostics.

A significant increase in the prevalence of genetic disorders has been observed since the recent past, thus driving the adoption of molecular diagnostics. Molecular diagnostic processes, including epigenetics and polymerase chain reaction (PCR), require molecular biology enzymes, kits and reagents, which are an integral part of these processes. Rising cases of genetic disorders in light of growing geriatric population will significantly fuel the demand for molecular biology enzymes, kits and reagents in the near future. The genetic data of individuals is considered highly confidential and the sharing of this data is strictly prohibited. Genome sequencing helps identify and treat a wide variety of diseases. However, there is a lack of effective tools to secure individuals’ genetic information, and the information ends up being stored in cloud databases, posing an additional data theft threat. The lack of efficient technology to store genetic information is expected to negatively influence the demand for molecular biology enzymes, kits and reagents.

Request a sample PDF brochure:

Key players:

  • Jena Bioscience GmbH
  • Takara Bio Inc.
  • Roche Management Inc.
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • KRISHGEN biological systems
  • Agilent Technologies Inc.
  • Qiagen AG
  • and Merck & Co Company.

Main research findings of the report

  • Although sequencing is expected to prevail as the largest application of molecular biology enzymes, kits and reagents in terms of revenue, synthetic biology is expected to persist as the fastest growing application segment in the market. . The cloning apps segment will also show an impressive expansion and account for the second largest revenue share of the market during the forecast period.
  • Academic and research institutes are expected to register the fastest expansion in the market through 2026, based on end users. However, the revenue of this end-user segment will still be comparatively lower than other end-user segments included in the report.
  • Revenue from sales of molecular biology enzymes, kits and reagents for pharmaceutical and biotechnology companies are expected to account for the largest market share from 2017 to 2026.
  • The kits and reagents will prevail as the best-selling and best-selling products in the market. Between modifying enzymes and restriction enzymes, the latter will exhibit relatively faster sales expansion, while the former will account for a larger share of market revenue till 2026.
  • North America is expected to remain the highest paying market for molecular biology enzymes, kits and reagents, followed by Asia-Pacific excluding Japan (APEJ).

Leading companies in the global molecular biology enzymes, kits and reagents market are implementing strategies including manufacturing capacity and geographical expansion. Manufacturers are also focusing on new product launches to increase their market share in this increasingly competitive market. The report has listed key players supporting market growth including Thermo Fisher Scientific Inc., Illumina, Inc., Roche Holdings, Inc., Takara Bio Inc., Jena Bioscience GmbH, Merck & Co Company, Qiagen NV, Agilent Technologies , Inc., KRISHGEN BioSystems and Promega Corporation.

Browse the full report:

Market segments:


  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • AEM

type of product

  • Kits and reagents
  • Modification of enzymes
  • Restriction enzymes
  • Other types of products

Final user

  • Pharmaceutical and biotechnology companies
  • Hospitals and diagnostic centers
  • Academic and research institutes
  • Other end users


  • Sequencing
  • Cloning
  • Polymerase chain reaction
  • Restricted digestion
  • Synthetic biology
  • Epigenetics
  • Other

Get in touch with our team to benefit from a flat rate discount of 20%:


Future Market Insights, Inc. is an ESOMAR certified business consulting and market research firm, member of the Greater New York Chamber of Commerce and headquartered in Delaware, USA. Recipient of the 2022 Clutch Leaders Award for high customer score (4.9/5), we have partnered with global companies on their business transformation journey and helped them realize their business ambitions. 80% of the Forbes 1000 largest companies are our clients. We serve global clients across all leading and niche market segments in all major industries.

Now enjoy flexible research subscriptions and access multiple research formats with downloadable data books, infographics, charts, an interactive reading book for data visualization, and comprehensive reports through MarketNgage, the research engine. market intelligence from Future Market Insights. Sign up for a 7 day free trial!


Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

Such. : +1-845-579-5705

Requests: [email protected]

LinkedIn|Twitter| Blogs

Comments are closed.